全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
-  2015 

头面部丛状神经纤维瘤的整形外科治疗

DOI: doi:10.7507/1002-1892.20150300

Keywords: 丛状神经纤维瘤, Ⅰ型神经纤维瘤病, 眶颞部, 血管栓塞

Full-Text   Cite this paper   Add to My Lib

Abstract:

目的探讨头面部丛状神经纤维瘤的整形外科治疗和控制术中出血的方法。 方法回顾性分析2004年7月-2013年7月收治的20例头面部丛状神经纤维瘤患者临床资料。男9例,女11例;年龄18~56岁,平均37岁。病程8~56年,平均19年。Ⅰ型神经纤维瘤病17例,单纯丛状神经纤维瘤3例。6例病变累及头皮,7例累及面部,7例同时累及头面部。病变累及范围4 cm×3 cm~15 cm×13 cm。2例瘤体表面皮肤色素改变明显。4例累及眶颞区者术前行肿瘤营养动脉血管栓塞。18例病变面积超过5 cm×5 cm者,于肿瘤切除前行瘤周缝线环扎预防出血。3例分两期切除瘤体,其余患者均一期手术切除;瘤体切除后行创面修复、面部矫形。 结果单次手术者术中出血量为100~500 mL,平均300 mL;两次手术者第1次术中出血量分别为500、600、800 mL,第2次均为50 mL。3例行自体血回输,回输量分别为200、400、400 mL。术后3~7 d,平均5 d拆除环扎缝线,术后未出现继发出血及血肿;切口均Ⅰ期愈合,皮瓣及植皮均成活良好。15例患者获随访,随访时间1~7年,平均2.5年。头面部外形明显改善,神经纤维瘤均未再出现明显生长隆起、下垂移位。 结论头面部丛状神经纤维瘤手术联合介入血管栓塞、瘤周环扎等控制出血措施,可减少术中出血量。手术方案应根据患者病情进行个性化处理,以减少瘤体负荷、改善外观及功能为主要目的

References

[1]  3. Korf BR. Plexiform neurofibromas. Am J Med Genet, 1999, 89(1):31-37.
[2]  5. Hivelin M, Wolkenstein P, Lepage C, et al. Facial aesthetic unit remodeling procedure for neurofibromatosis type 1 hemifacial hypertrophy:report on 33 consecutive adult patients. Plast Reconstr Surg, 2010, 125(4):1197-1207.
[3]  6. Marchac D, Britto JA. Remodelling the upper eyelid in the management of orbitopalpebral neurofibromatosis. Br J Plast Surg, 2005, 58(7):944-956.
[4]  13. Coban-Karatas M, Altan-Yaycioglu R, Bal N, et al. Management of facial disfigurement in orbitotemporal neurofibromatosis. Ophthal Plast Reconstr Surg, 2010, 26(2):124-126.
[5]  16. Pelage JP, Le Dref O, Mateo J, et al. Life-threatening primary postpartum hemorrhage:treatment with emergency selective arterial embolization. Radiology, 1998, 208(2):359-362.
[6]  18. Jones RG, Kiatisevi P, Morris DC, et al. Intravascular embolisation and surgical resection of a giant neurofibroma with intratumoural hemorrhage. Br J Radiol, 2010, 83(995):e225-229.
[7]  2. 郝永红, 宋慧峰, 许明火, 等. 巨大神经纤维瘤病诊断及整形外科治疗. 中国美容医学, 2013, 22(16):1724-1727.
[8]  9. Erb MH, Uzcatequi N, See RF, et al. Orbitotemporal neurofibromatosis:classification and treatment. Orbit, 2007, 26(4):223-228.
[9]  1. Lee V, Ragge NK, Collin JR. Orbitotemporal neurofibromatosis. Clinical features and surgical management. Ophthalmology, 2004, 11(2):382-388.
[10]  4. 王炜, 林晓曦, 祁佐良, 等. 面部神经纤维瘤的整形和显微外科治疗. 上海医学, 2000, 23(7):387-389.
[11]  7. 王炜. 整形外科学. 杭州:浙江科学技术出版社, 1999:460-461.
[12]  8. Van der Meulen JC, Moscona AR, Vandrachen M, et al. The management of orbitofacial neurofibromatosis. Ann Plast Surg, 1982, 8(3):213-220.
[13]  10. Singhal D, Chen YC, Chen YR, et al. Soft tissue management of orbitotemporal neurofibromatosis. J Craniofac Surg, 2013, 24(1):269-272.
[14]  11. Li J, Lin M, Shao C, et al. Blepharoplasty techniques in the management of orbito-temporal neurofibromatosis. J Plast Reconstr Aesthet Surg, 2014, 67(11):1496-1501.
[15]  12. Bechtold D, Hove HD, Prause JU, et al. Plexiform neurofibroma of the eye region occurring in patients without neurofibromatosis type 1. Ophthal Plast Reconstr Surg, 2012, 28(6):413-415.
[16]  14. White N, Gwanmesia I, Akhtar N, et al. Severe haemorrhage in neurofibromatoma:a lesson. Br J Plast Surg, 2004, 57(5):456-457.
[17]  15. Tomei KL, Gupta V, Prestigiacomo CJ, et al. Spontaneous hemorrhage of a facial neurofibroma:endovascular embolization before surgical intervention. J Craniofac Surg, 2013, 24(5):e514-517.
[18]  17. Lin YC, Chen HC. Rare complication of massive hemorrhage in neurofibromatosis with arteriovenous malformation. Ann Plast Surg, 2000, 44(2):221-224.
[19]  19. Konno E, Kishi K. Use of the LigaSureTM vessel sealing system in neurofibroma excision to control postoperative bleeding. J Plast Reconstr Aesthet Surg, 2012, 65(6):814-817.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133